Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-27T01:06:17.638Z Has data issue: false hasContentIssue false

Comparison of the effect of inhaled nitric oxide and intravenous nitroglycerine on hypoxia-induced pulmonary hypertension in pigs

Published online by Cambridge University Press:  04 August 2006

E. Troncy
Affiliation:
Department of Anaesthesiology, Hôpital Notre-Dame, Université de Montréal, 1560 Sherbrooke Street East, Montreal, Quebec, Canada
E. Jacob
Affiliation:
Department of Anaesthesiology, Hôpital Notre-Dame, Université de Montréal, 1560 Sherbrooke Street East, Montreal, Quebec, Canada
E. Peres da Silva
Affiliation:
Department of Anaesthesiology, Hôpital Notre-Dame, Université de Montréal, 1560 Sherbrooke Street East, Montreal, Quebec, Canada
T. Ducruet
Affiliation:
Department of Anaesthesiology, Hôpital Notre-Dame, Université de Montréal, 1560 Sherbrooke Street East, Montreal, Quebec, Canada
J.-P. Collet
Affiliation:
Department of Anaesthesiology, Hôpital Notre-Dame, Université de Montréal, 1560 Sherbrooke Street East, Montreal, Quebec, Canada
I. Salazkin
Affiliation:
Department of Anaesthesiology, Hôpital Notre-Dame, Université de Montréal, 1560 Sherbrooke Street East, Montreal, Quebec, Canada
M. Charbonneau
Affiliation:
Department of Anaesthesiology, Hôpital Notre-Dame, Université de Montréal, 1560 Sherbrooke Street East, Montreal, Quebec, Canada
G. Blaise
Affiliation:
Department of Anaesthesiology, Hôpital Notre-Dame, Université de Montréal, 1560 Sherbrooke Street East, Montreal, Quebec, Canada
Get access

Abstract

Pulmonary hypertension is usually treated with intravenous (i.v.) vasodilators, but their use is limited by systemic effects. In the current study, we compared the effects of inhaled nitric oxide and intravenous nitroglycerine on pulmonary and systemic haemodynamic responses as well as on gas exchange measurements in anaesthetized pigs whose pulmonary pressure was increased by hypoxia (FiO2 = 15%). Both treatments reduced pulmonary pressure to the control level. Inhaled nitric oxide did not affect systemic arterial pressure but intravenous nitroglycerine decreased it from 126.2 to 108.8 mmHg (P = 0.04). Unlike intravenous nitroglycerine, inhaled nitric oxide increased arterial PaO2 from 5.3 to 5.9 kPa (P = 0.02). Both treatments diminished central venous pressure and left atrial pressure, suggesting a possible cardiac effect. Inhaled nitric oxide was shown to be a potent pulmonary vasodilator which attenuated pulmonary hypertension and improved arterial oxygenation without important direct effects on systemic pressure in porcine hypoxia-induced pulmonary hypertension.

Type
Original Article
Copyright
1996 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)